Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4930
+0.0250 (5.34%)
At close: Dec 5, 2025
Medicofarma Biotech Company Description
Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations.
It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests.
The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in February 2021.
Medicofarma Biotech SA was founded in 2001 and is headquartered in Warsaw, Poland. The company operates as a subsidiary of Vitama Spolka Akcyjna.
Medicofarma Biotech SA
| Country | Poland |
| Founded | 2001 |
| Industry | Biotechnology & Medical Research |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Cezary Kilczewski |
Contact Details
Address: Sokolowska 9/lok.U19 Warsaw, 01-142 Poland | |
| Phone | 48 32 268 6405 |
| Website | medicofarmabiotech.pl |
Stock Details
| Ticker Symbol | MDB |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Cezary Kilczewski | Chief Executive Officer |